Galapagos Company

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.

Headquarters: Mechelen-bovelingen, Limburg, Belgium
Investors Number: 6.0
Last Funding Type: Post-IPO Equity
Funding Status: IPO
Total Funding: 5446287155.0
Last Funding Date: 2019-07-14
Founded Date: 1999-01-01
Industry: Clinical Development
Estimated Revenue: $100M to $500M